Intravenous Ganaxolone as Adjunctive Therapy to Treat Subjects With Status Epilepticus

NCT03350035 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

17

Enrollment

INDUSTRY

Sponsor class

Conditions

Status Epilepticus
Convulsive Status EPILEPTICUS
Non Convulsive Status Epilepticus
Epilepsy

Interventions

DRUG: IV Ganaxolone active
DRUG: IV Placebo, non-active

Sponsor

Marinus Pharmaceuticals